Volume 5, Problème 1 (2015)
Méthodologie du parcours clinique
Application of biomarkers in oncology clinical trials
Naveen Dakappagari, Hua Gong, Reinhold Pollner, Amara Siva, Shabnam Tangri & Jelveh Lameh
Évaluation des médicaments
Review of tofacitinib in rheumatoid arthritis
Maria A Lopez-Olivo, Huifang Lu & Jean H Tayar
Article de révision
Angiokinase inhibitors in non-small-cell lung cancer
Wei-Chen Lu, Chia-Chi Lin, & James Chih-Hsin Yang
Perspective
Challenges of combining cytotoxic chemotherapy and tyrosine kinase inhibitors
Michael P Chu, Vijaya L Damaraju & Michael B Sawyer
Résultats des essais cliniques
Chemotherapeutic treatment of acute myeloid leukemia: incorporating the results of recent clinical trials
Ali J Mahdi, Eamon J Mahdi & Steven Knapper
Résultats des essais cliniques
Cancer therapy with Newcastle disease virus: rationale for new immunotherapeutic combinations
Tamar Plitt & Dmitriy Zamarin
Évaluation des médicaments
Clinical rationale of sucroferric oxyhydroxide for controlling hyperphosphatemia in patients with chronic kidney disease
Stuart M Sprague, Morgan Marcuccilli & Viatcheslav Rakov
